The tumor, which occurs when supportive cells in the brain grow and divide uncontrollably, is extremely aggressive and deadly. Most patients survive only 14 to 16 months after diagnosis.

On the latest episode of "The Conversation," KSAT’s Stephania Jimenez spoke with a local doctor about glioblastoma and a ...

A new immunotherapy trial for the deadliest form of brain cancer, glioblastoma, is now recruiting patients after one individual experienced a remarkable outcome, seeing his tumour vanish. The NHS ...